Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease

doi:10.12998/wjcc.v9.i36.11285

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6165)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

390

WORD

113

HTML

2590

Figures (1-2)

527

Tables (1-5)

364

Sum=3984

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

454

Download

1727

Sum=2181

Dec 26, 2021 (publication date) through Apr 18, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. Dec 26, 2021; 9(36): 11285-11299
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11285

Table 5 Type of adverse events reported, n (%)

Number of AEs¹	34 (15.45)
Hypersensitivity	9 (26.5)
Malignant neoplasm	1 (2.9)
Infections (any type)	8 (23.5)
Respiratory infections	2 (5.9)
Other infections	6 (17.6)
Other AEs	8 (23.5)
Non-specified	8 (23.5)

¹Any type. AEs: Adverse events.

Citation: Huguet JM, Cortés X, Bosca-Watts MM, Aguas M, Maroto N, Martí L, Amorós C, Paredes JM. Real-world data on the infliximab biosimilar CT-P13 (Remsima^®) in inflammatory bowel disease. World J Clin Cases 2021; 9(36): 11285-11299
URL: https://www.wjgnet.com/2307-8960/full/v9/i36/11285.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i36.11285